LEAC-102 for Advanced Colorectal Cancer

Clinical trial NCT02826837 · UNKNOWN

Trial details

NCT number: NCT02826837
Sponsor: Taiwan Leader Biotech Corp.
Status: UNKNOWN
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Advanced Colorectal Cancer

Start date: 2022-09-01
Primary completion: 2024-02-01
Enrollment: 30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.